Glipizide and Gemzar drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Glipizide (glipizide) and Gemzar (gemcitabine hydrochloride). Common drug interactions include dyspnoea among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Glipizide and Gemzar. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.
What is Glipizide?
Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.
What is Gemzar?
Gemzar has active ingredients of gemcitabine hydrochloride. It is often used in pancreatic carcinoma. eHealthMe is studying from 20,315 Gemzar users. Check the latest studies of Gemzar.
54 people who take Glipizide and Gemzar together, and have interactions are studied.

What are the common drug interactions of Glipizide and Gemzar, by gender? *:
female:
- Dyspnoea (difficult or laboured respiration)
- Malignant neoplasm progression (cancer tumour came back)
- Pneumonia
- Renal failure (kidney dysfunction)
- Alopecia (absence of hair from areas of the body)
- Hair colour changes
- Hair disorder
- Abortion induced (medically referred abortion)
- Adenocarcinoma pancreas (cancer of pancreas)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
male:
- Dyspnoea (difficult or laboured respiration)
- Oedema peripheral (superficial swelling)
- Infection
- Inflammation
- Pleural effusion (water on the lungs)
- Actinomycosis (infection that causes sores, or abscesses)
- Alveolar osteitis (complication of wound healing following extraction of a tooth)
- Arthralgia (joint pain)
- Balance disorder
- Blood creatinine increased
What are the common drug interactions of Glipizide and Gemzar, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Ataxia (loss of full control of bodily movements)
- Convulsions (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled of muscles contract and relax rapidly and repeatedly)
- Dizziness (excl vertigo)
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Fall
- Haemorrhage (bleeding)
- Hypoaesthesia (reduced sense of touch or sensation)
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
- Postural hypotension
50-59:
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
- Epidural lipomatosis (excessive accumulation of fat within the epidural space -brain)
- Exostosis (formation of new bone on the surface of a bone)
- Fungal infection
- Gait disturbance
- Haematoma (collection of blood outside the blood vessels)
- Hypertension (high blood pressure)
- Hypoxia (low oxygen in tissues)
- Incisional drainage
- Infection
60+:
- Asthenia (weakness)
- Abdominal pain
- Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Chest pain
- Colon cancer
- Cough
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Escherichia infection (bacterial infection by escherichia coli)
- Haemoglobin decreased
What are the existing conditions these people have? *
- Pain: 15 people, 27.78%
- Metastases To Bone (cancer spreads to bone): 8 people, 14.81%
- Nausea (feeling of having an urge to vomit): 5 people, 9.26%
- Breast Cancer Metastatic: 5 people, 9.26%
- Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 7.41%
- High Blood Pressure: 4 people, 7.41%
- Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 3 people, 5.56%
- Lung Cancer - Non-Small Cell (lung cancer): 3 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Glipizide and Gemzar?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Glipizide and Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Glipizide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Gemzar:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Glipizide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Gemzar and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
- Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on glipizide and gemcitabine hydrochloride (the active ingredients of Glipizide and Gemzar, respectively), and Glipizide and Gemzar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pantosin cause Insomnia? - 20 seconds ago
- Antacid Therapy and Pain Exacerbated - 28 seconds ago
- Could Humulin R cause Breath Odor? - 31 seconds ago
- Could Aromasin cause Crohn'S Disease Aggravated? - 35 seconds ago
- Could Accolate cause Pancytopenia? - 35 seconds ago
- Anaemia and Night Sweats - 43 seconds ago
- Could Anzemet cause Atrial Fibrillation/Flutter? - 47 seconds ago
- Agoraphobia and Fall - 58 seconds ago
- Could Lupron cause Myositis? - a minute ago
- Could Xenazine cause Nightmares? - a minute ago